HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Proparacaine

HCID 4935
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
499-67-2
Standard SMILES
CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N
InChIKey
KCLANYCVBBTKTO-UHFFFAOYSA-N
Molecular formula
C16H26N2O3
Average molar mass
294.39 g/mol
Monoisotopic mass
294.1943427

Overview

Proparacaine is a benzoate ester.

Names & identifiers

Preferred name
Proparacaine
IUPAC
2-(diethylamino)ethyl 3-amino-4-propoxybenzoate
English name
proxymetacaine
Molecular formula
C16H26N2O3
Molecular weight
294.39

Names & synonyms

proparacaineProxymetacaine499-67-22-(Diethylamino)ethyl 3-amino-4-propoxybenzoateProximetacainumProximetacainaProssimetacainaProxymetacainum3-Amino-4-propoxybenzoic acid 2-(diethylamino)ethyl esterBENZOIC ACID, 3-AMINO-4-PROPOXY-, 2-(DIETHYLAMINO)ETHYL ESTERB4OB0JHI1XDTXSID30198146
Show more names
C07383FlucaineFluoracaineChibro-keracaineProxymetacaineHclProxymethacaineHClproxymetacaine USP/EP/BPProxymethacainehydrochloride
proxymethacaineRefChem:58606DTXCID60120637S01HA04207-884-9OphthaineProssimetacaina [DCIT]Proxymetacainum [INN-Latin]

Database identifiers

CAS
499-67-2
PubChem CID
4935
DTXSID
DTXSID30198146
ChEMBL

Properties

Computed structural properties

XLogP
2.7
Topological polar surface area
64.8 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
10
Heavy atoms
21
Formal charge
0
Complexity
295

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.5
Solubility · 2 items

Soluble

1.39e+00 g/L

Human DrugsPharmaceuticals
Melting Point · 2 items

182-183.3 °C

182 - 183.3 °C

Physical DescriptionSolid
Dissociation Constants3.2

Physicochemical properties

Melting point
182 · 182-183.30C
Boiling point
434.4 · 434.4±35.0 °C(Predicted)
Density
1.065 · 1.065
storage temp.
Refrigerator

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Exposure RoutesTopical (eye drop).
Toxicity Summary · 1 item

The exact mechanism whereby proparacaine and other local anesthetics influence the permeability of the cell membrane is unknown; however, several studies indicate that local anesthetics may limit sodium ion permeability through the lipid layer of the nerve cell membrane. Proparacaine may alter epithelial sodium channels through interaction with channel protein residues. This limitation prevents the fundamental change necessary for the generation of the action potential.

Signs and Symptoms · 1 item

Dizziness or drowsiness; increased sweating; irregular heartbeat; muscle twitching or trembling; nausea or vomiting; shortness of breath or troubled breathing; unusual excitement, nervousness, or restlessness; unusual tiredness or weakness. Burning, stinging, redness, or other irritation of eye. (L1482)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Safety data

wgk
WGK 3
Storage Class
11 - Combustible Solids

Chemistry & industry

Pharmacology

ATC Code · 2 items

S - Sensory organs

QS - Sensory organs

Pharmacodynamics · 1 item

Proparacaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. More specifically, proparacaine appears to bind or antagonize the function of voltage gated sodium channels.

Mechanism of Action · 1 item

The exact mechanism whereby proparacaine and other local anesthetics influence the permeability of the cell membrane is unknown; however, several studies indicate that local anesthetics may limit sodium ion permeability through the lipid layer of the nerve cell membrane. Proparacaine may alter epithelial sodium channels through interaction with channel protein residues. This limitation prevents the fundamental change necessary for the generation of the action potential.

Metabolism/Metabolites · 2 items

Plasma

Plasma

FDA Pharmacological Classification · 5 items

B4OB0JHI1X

PROPARACAINE

Physiologic Effects [PE] - Local Anesthesia

Established Pharmacologic Class [EPC] - Local Anesthetic

Proparacaine is a Local Anesthetic. The physiologic effect of proparacaine is by means of Local Anesthesia.

MeSH Pharmacological Classification · 1 item

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Cellular Locations

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEMBL1196
ChEBI
CHEBI:8485
UNII
B4OB0JHI1X
EC Number
207-884-9
Nikkaji
J6.177H
pka
9.2 · 9.20±0.25(Predicted)
form
solid
Major Application
pharmaceuticalpharmaceutical small molecule
InChI
1S/C16H26N2O3.ClH/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3;/h7-8,12H,4-6,9-11,17H2,1-3H3;1H
InChIKey
BFUUJUGQJUTPAF-UHFFFAOYSA-N
SMILES
[Cl-].[N+H](CCOC(=O)c1cc(c(cc1)OCCC)N)(CC)CC
FDA UNII
4 OB0JHI1X · B4OB0JHI1X
ATC code
1 HA04 · S01HA04
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids
Extracellular
Metabolite PathwaysProparacaine Action Pathway

Uses & manufacturing

UsesUsed as an ophthalmic anesthetic (as eye drops) to reduce pain and discomfort during procedures involving the eye. [Wikipedia]
Use ClassificationPharmaceuticals

Applications

UsesTopical anesthetic (ophthalmic)

Suppliers15 total

北京华美互利生物化工010-56205725 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
Changzhou lan-Novo Pharmaceutical Co., Ltd.+86-13915082169 · [email protected]
成都圣美凯生物科技有限公司028-85157043 15882256948 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
上海杰股生物科技有限公司021-51698675 · [email protected]
重庆卡兰医药有限公司[email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
Dideu Industries Group Limited+86-29-81148696 +86-15129568250 · [email protected]
南京世洲生物科技有限公司025-85563444 15850508050 · [email protected]

Additional notes

DefinitionChEBI: Proparacaine is a benzoate ester.